Contract HHSO100201500014C

Janssen Pharmaceuticals, Inc. · Department Of Health And Human Services · September 21, 2015

Cost Plus Fixed FeeFull & Open CompetitionNAICS 541711

Janssen Pharmaceuticals, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 21, 2015 for $127.53 million of work in research and development in biotechnology. It was awarded under full and open competition. The contract has been modified 13 times since the base award It uses cost-plus contract pricing. The most recent modification was on April 20, 2026.

Obligated to date
$127.53M
$127,528,456
Potential value
$127.53M
if all options exercised
Modifications
13
Latest April 20, 2026

Contract details

PIID
HHSO100201500014C
Award type
Pricing
Cost Plus Fixed Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541711 · Research And Development In Biotechnology
Product / service
Health R&D Services; Health Care Services; Basic Research
First action
September 21, 2015
Latest action
April 20, 2026

Description

DE-OBLIGATION AND CLOSEOUT OF THE CONTRACT IN ITS ENTIRETY.

Modification timeline

  • April 20, 2026
    Mod P00013
    $-50.82M
  • October 21, 2021
    Mod P00012
    ALL CLINS WILL END EFFECTIVE, 9/30/2021
    $0
  • May 12, 2020
    Mod P00011
    MODIFICATION P00011 ADDRESSES THE FOLLOWING: (1) REALLOCATE FUNDS FROM CLINS 0001, 0003, 0004, 0011, 0012, AND 0013 TO CLIN 0005. (2) ADD $34,800,000 IN SUPPLE
    $34.80M
  • May 9, 2019
    Mod P00010
    IGF::OT::IGF
    $0
  • July 26, 2018
    Mod 9
    IGF::OT::IGF
    $0
  • January 13, 2018
    Mod 8
    IGF::OT::IGF
    $24.32M
  • November 6, 2017
    Mod 7
    IGF::OT::IGF
    $0
  • September 5, 2017
    Mod 6
    IGF::OT::IGF
    $9.91M
  • July 18, 2017
    Mod 5
    IGF::OT::IGF
    $0
  • May 13, 2016
    Mod 4
    IGF::OT::IGF
    $1.88M

Similar contracts

RecipientAgencyDateObligated
University Of IllinoisDepartment Of Health And Human ServicesMarch 26, 2026$2.27M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 25, 2026$9.65M
University Of Texas Medical Branch At GalvestonDepartment Of Health And Human ServicesMarch 23, 2026$1.61M
Regeneron Pharmaceuticals IncDepartment Of Health And Human ServicesMarch 19, 2026$8.60M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.23M
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 17, 2026$2.22M

Top contractors in NAICS 541711

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HHSO100201500014C?

Contract HHSO100201500014C is a federal contract awarded to Janssen Pharmaceuticals, Inc. by Department Of Health And Human Services on September 21, 2015 for $127.53 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 13 times since the base award.

Who won contract HHSO100201500014C?

Janssen Pharmaceuticals, Inc. won contract HHSO100201500014C from Department Of Health And Human Services.

How much is contract HHSO100201500014C worth?

Contract HHSO100201500014C has obligated $127.53 million to date.